Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Manchester United PLC — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Manchester United PLC trades at $20.68 (market cap $3.64B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.5× Manchester United PLC's market cap, and Manchester United PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals.
| GEHC | MANU | |
|---|---|---|
Market Cap | $31.07B | $3.64B |
Volume | 3,443,020 | 324,608 |
Sector | Health | Media |
52-Week High | $88.16 | $24.19 |
52-Week Low | $59.48 | $15.20 |
Enterprise Value | $39.53B | $4.46B |
Dividend Yield | 0.23% | 1.26% |
Typical Hold Time | — | 109 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Manchester United (MANU) trades at $20.59, down 1.15% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported fiscal 2026 revenue of $678 million with improved EBITDA of $216.4 million despite net losses, while analyst sentiment remains divided with 40% buy ratings. Recent news highlights the stock trading at a significant discount to Forbes' $7.2 billion franchise valuation estimate.
Investment outlook balances franchise value upside against persistent profitability challenges. Key opportunities include Champions League return and cost controls, while risks center on sustained losses, high debt, and competitive Premier League dynamics. The stock offers speculative appeal for franchise value believers but requires profitability improvement for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
